BIOTRICITY INC (BTCY) Stock Price, Forecast & Analysis
USA - NASDAQ:BTCY - US09074H2031 - Common Stock
BTCY Key Statistics, Chart & Performance
The current stock price of BTCY is 0.4631 USD. In the past month the price decreased by -39.51%. In the past year, price decreased by -81.7%.
BTCY Latest News, Press Relases and Analysis
BTCY Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.38 | 48.08B | ||
| DOCS | DOXIMITY INC-CLASS A | 30.26 | 9.29B | ||
| WAY | WAYSTAR HOLDING CORP | 26.36 | 6.74B | ||
| HTFL | HEARTFLOW INC | N/A | 2.33B | ||
| CERT | CERTARA INC | 16.66 | 1.34B | ||
| PHR | PHREESIA INC | N/A | 1.30B | ||
| SDGR | SCHRODINGER INC | N/A | 1.30B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.22B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 624 | 1.06B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.49 | 1.03B | ||
| HSTM | HEALTHSTREAM INC | 35.99 | 725.29M |
Related stock screener links
About BTCY
Company Profile
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 55 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
Company Info
BIOTRICITY INC
203 Redwood Parkway, Suite 600
Redwood City CALIFORNIA US
Employees: 55
Phone: 16508321626
BIOTRICITY INC / BTCY FAQ
What does BTCY do?
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 55 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
What is the current price of BTCY stock?
The current stock price of BTCY is 0.4631 USD. The price decreased by -28.31% in the last trading session.
What is the dividend status of BIOTRICITY INC?
BTCY does not pay a dividend.
How is the ChartMill rating for BIOTRICITY INC?
BTCY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for BIOTRICITY INC?
BIOTRICITY INC (BTCY) operates in the Health Care sector and the Health Care Technology industry.
When is the next dividend date for BIOTRICITY INC (BTCY)?
The next ex-dividend date for BIOTRICITY INC (BTCY) is February 23, 2022.
Can you provide the short interest for BTCY stock?
The outstanding short interest for BIOTRICITY INC (BTCY) is 1.13% of its float.
BTCY Technical Analysis
BTCY Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BTCY. BTCY may be in some trouble as it scores bad on both profitability and health.
BTCY Financial Highlights
Over the last trailing twelve months BTCY reported a non-GAAP Earnings per Share(EPS) of -1.66. The EPS increased by 26.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -251.17% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BTCY Forecast & Estimates
6 analysts have analysed BTCY and the average price target is 4.08 USD. This implies a price increase of 781.02% is expected in the next year compared to the current price of 0.4631.
For the next year, analysts expect an EPS growth of 73.56% and a revenue growth 19.17% for BTCY